E-Li Wang

Statistics

Publications

Citations

132

H-Index

Active since

2019

Affiliations

Xiangya Hospital Central South University(Current)

Central South University

Hunan Children's Hospital

Third Xiangya Hospital

E-Li Wang is an author at Xiangya Hospital Central South University specializing in pulmonary hypertension, hypoxia-induced pulmonary hypertension, and pharmacology.

Publications per year

2019–2023

Publications

Magnesium lithospermate B prevents phenotypic transformation of pulmonary arteries in rats with hypoxic pulmonary hypertension through suppression of NADPH oxidase

Tao Li, Xiu‐Ju Luo, E-Li Wang et al. · European Journal of Pharmacology · 2019 · 38 citations

Medicine, Biochemistry, Pharmacology +12

Magnolol Attenuates Right Ventricular Hypertrophy and Fibrosis in Hypoxia-Induced Pulmonary Arterial Hypertensive Rats Through Inhibition of the JAK2/STAT3 Signaling Pathway

Minyi Fu, Fangmei Luo, E-Li Wang et al. · Frontiers in Pharmacology · 2021 · 35 citations · Full text

Medicine, Cardiology, Pharmacology +14

Cerebellin-2 promotes endothelial-mesenchymal transition in hypoxic pulmonary hypertension rats by activating NF-κB/HIF-1α/Twist1 pathway

E-Li Wang, Jie-Jie Zhang, Fangmei Luo et al. · Life Sciences · 2023 · 26 citations

Life Sciences, Cell Biology, Molecular Biology +15

Coordination between NADPH oxidase and vascular peroxidase 1 promotes dysfunctions of endothelial progenitor cells in hypoxia-induced pulmonary hypertensive rats

E-Li Wang, Miaomiao Jia, Fangmei Luo et al. · European Journal of Pharmacology · 2019 · 17 citations

Life Sciences, Cell Biology, Physiology +17

Magnesium Lithospermate B Derived from Salvia miltiorrhiza Ameliorates Right Ventricle Remodeling in Pulmonary Hypertensive Rats via Inhibition of NOX/VPO1 Pathway

Tao Li, Jing-Jie Peng, E-Li Wang et al. · Planta Medica · 2019 · 16 citations

Life Sciences, Cardiology, Pharmacology +16

1–5 of 5